vaccines Archives | Page 2 of 18

Interim Estimates of 2022–23 Seasonal Influenza Vaccine Effectiveness — Wisconsin, October 2022–February 2023

CDC/MMWR

24 February 2023

McLean HQ, Petrie JG, Hanson KE, et al.
The 2022–23 influenza vaccine provides substantial protection against circulating influenza A viruses and remains the best way to protect against influenza. Influenza vaccination is recommended as long as influenza viruses are circulating.

keywords: Influenza Virus, vaccines

Association of COVID-19 Vaccination With Risk for Incident Diabetes After COVID-19 Infection (Website)

JAMA Open Network

14 February 2023

Kwan, A., et.al
Diabetes risk after COVID-19 infection was higher in unvaccinated than vaccinated patients, suggesting a benefit of vaccination.

keywords: covid-19, diabetes, vaccines

COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination — 24 U.S. Jurisdictions, October 3, 2021–December 24, 2022 (Website, Regulatory)

CDC/MMWR

10 February 2023

Johnson AG, Linde L, Ali AR, et al.

keywords: bivalent, covid-19, vaccines

Early Treatment with Pegylated Interferon Lambda for Covid-19 (Website)

The New England Journal of Medicine (NEJM)

9 February 2023

Reis G, et.al.
Among predominantly vaccinated outpatients with Covid-19, the incidence of hospitalization or an emergency department visit was significantly lower among those who received a single dose of pegylated interferon lambda than among those who received placebo.

keywords: covid-19, interferon, treatment, vaccines

Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, December 2022–January 2023 (Website, Regulatory)

CDC/MMWR

3 February 2023

Link-Gelles R, Ciesla AA, Roper LE, et al.

keywords: covid-19, mRNA, omicron, vaccines

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years — IVY Network, 18 States, September 8–November 30, 2022 (Website, Publication, Regulatory)

CDC/MMWR

30 December 2022

Surie D, DeCuir J, Zhu Y, et al.

keywords: bivalent, covid-19, immunocompetant adults, older adults, vaccines

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022 (Website, Publication, Regulatory)